Hyperandrogenism due to Cortisone Reductase Deficiency: A Patient Guide
At a Glance
Cortisone reductase deficiency is a rare hormone disorder in which cortisol is broken down too quickly, prompting the adrenal glands to make extra androgen hormones. A 24-hour urine steroid profile helps identify it, and titrated glucocorticoid treatment can restore hormone balance and support growth.
Cortisone Reductase Deficiency (CRD), often referred to as Apparent Cortisone Reductase Deficiency (ACRD), is a rare condition that changes how the body manages its “recycling” of vital hormones. In a healthy system, the body efficiently converts inactive cortisone into active cortisol, the hormone responsible for managing stress and metabolism. In people with ACRD, a genetic mutation (typically in the HSD11B1 or H6PD genes) impairs this recycling pathway [1].
Because of this impaired cortisone-to-cortisol conversion, cortisol is cleared from the body more quickly than normal [1]. The brain perceives this increased clearance and sends constant signals (using a hormone called ACTH) to the adrenal glands to work harder. This forces the adrenal glands into a state of hyperactivity. While they produce more cortisol to meet the demand, they also produce an excess of androgens (often called “male-type” hormones, though they are present in everyone) [1][2]. It is this overproduction of androgens that causes the physical symptoms of the condition [1].
Important Note: Rapid virilization—such as marked voice deepening or clitoral enlargement—has many causes and requires prompt medical assessment to rule out tumors or other acute issues. Typical symptoms of ACRD are not an emergency, but you should seek evaluation if changes occur suddenly.
The impact of this hormonal imbalance varies depending on when it is discovered. In children, the excess androgens often lead to premature pubarche, where signs like body hair or acne appear years earlier than expected [2]. This is frequently accompanied by a rapid “growth spurt” and advanced bone maturation, which can lead to a shorter final adult height if the process is not managed [2]. In menstruating adults, the condition often mimics the signs of Polycystic Ovary Syndrome (PCOS), manifesting as persistent acne, excess facial or body hair, and irregular menstrual cycles [3].
Identifying ACRD requires clinical suspicion because its symptoms overlap closely with more common endocrine disorders. The diagnosis integrates clinical findings with a specialized 24-hour urinary steroid profile, which reveals a specific biological “fingerprint” of the recycling failure that standard blood tests often miss [4]. Because it is so rare, patients frequently undergo testing for more common conditions like Congenital Adrenal Hyperplasia (CAH) before the true source of the hormone imbalance is uncovered.
Managing ACRD is a long-term journey focused on restoring balance to the adrenal system. By using carefully titrated glucocorticoid medications, doctors can calm the overactive adrenal glands and lower androgen levels. For children, this management is a careful, ongoing process intended to protect their growth potential while managing physical symptoms [2]. With the guidance of an experienced endocrinologist, patients can effectively manage the condition and lead healthy lives [5].
In this guide
6 chapters
Building Your Knowledge of Cortisone Reductase Deficiency
Learn how cortisone reductase deficiency causes excess androgens, early puberty signs, acne, irregular periods, and how urine and genetic testing aid diagnosis.
Identifying the Signs of Cortisone Reductase Deficiency
Learn the signs of apparent cortisone reductase deficiency, including puberty changes, rapid growth, hirsutism, irregular periods, acne, and advanced bone age.
The Biology of ACRD: Impaired Hormone Conversion
Learn how ACRD impairs cortisone-to-cortisol conversion, raises ACTH and androgens, and how a urinary steroid profile helps distinguish it from NCCAH or PCOS.
Diagnosis and Deciphering Your Lab Results
Learn how apparent cortisone reductase deficiency lab results are interpreted, including urinary steroid testing, the THF/THE ratio, 17-OHP, and genetics.
Treatment and Balancing Hormone Management
Learn how apparent cortisone reductase deficiency treatment balances steroid choices, androgen control, growth, and stress-dose planning for children and adults.
Long-Term Health and Quality of Life with ACRD
Learn how apparent cortisone reductase deficiency affects growth, bone health, metabolism, and adrenal function, covering medication safety and quality of life.
Common questions in this guide
What is cortisone reductase deficiency, and why can it cause excess androgens?
What symptoms can apparent cortisone reductase deficiency cause?
How is ACRD diagnosed?
What do HSD11B1 and H6PD gene changes have to do with ACRD?
How is cortisone reductase deficiency treated?
Does sudden voice deepening or clitoral enlargement need urgent evaluation?
Get notified when new evidence is published on Hyperandrogenism due to cortisone reductase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (5)
- 1
Alterations of Cortisol Metabolism in Human Disorders.
White PC
Hormone research in paediatrics 2018; (89(5)):320-330 doi:10.1159/000485508.
PMID: 29843121 - 2
A follow-up history of young man with apparent cortisone reductase deficiency (ACRD) - several years after diagnosis.
Zajkowska A, Rydzewska M, Wojtkielewicz K, et al.
Pediatric endocrinology, diabetes, and metabolism 2017; (23(1)):42-48 doi:10.18544/PEDM-23.01.0073.
PMID: 29073307 - 3
Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia.
Schernthaner-Reiter MH, Baumgartner-Parzer S, Egarter HC, et al.
The journal of sexual medicine 2019; (16(10)):1529-1540 doi:10.1016/j.jsxm.2019.07.009.
PMID: 31447379 - 4
Estimation of reference curves for the urinary steroid metabolome in the first year of life in healthy children: Tracing the complexity of human postnatal steroidogenesis.
Dhayat NA, Frey AC, Frey BM, et al.
The Journal of steroid biochemistry and molecular biology 2015; (154()):226-36.
PMID: 26297192 - 5
Congenital Adrenal Hyperplasia.
Fraga NR, Minaeian N, Kim MS
Pediatrics in review 2024; (45(2)):74-84 doi:10.1542/pir.2022-005617.
PMID: 38296783
This page is for informational purposes only and does not constitute medical advice. It explains cortisone reductase deficiency, but an endocrinologist should interpret your test results and treatment needs; seek prompt assessment for sudden virilization or other rapidly changing symptoms.